Holocene Advisors, LP Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Holocene Advisors, LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $55.5 Million - $72.2 Million	299,400 Added 100.0%	598,800 $142 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $12.9 Million - $18.1 Million	106,900 Added 55.53%	299,400 $43.7 Million
Q4 2021 Feb 14, 2022	SELL	$159.56 - $209.29 $60.9 Million - $79.8 Million	-381,500 Reduced 66.46%	192,500 $32.6 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $55.8 Million - $68.3 Million	329,000 Added 134.29%	574,000 $108 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $31.5 Million - $43.3 Million	245,000 New	245,000 $41.5 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.